Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transanal Surgery vs Miles Surgery in Almost-cCR Rectal Cancer
NCT03431428Phase 3Unknown
- Start
- Jan 2018
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal cancer (2 arms). Primary endpoints: Progression-Free Survival at 3 years and Overall Survival at 3 years. Status: unknown.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT03431428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431428.